Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print December 16, 2005, doi:10.1212/01.wnl.0000192307.15103.83)
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
01.wnl.0000192307.15103.83v1
66/1_suppl_1/S97    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moreira, P. I.
Right arrow Articles by Perry, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moreira, P. I.
Right arrow Articles by Perry, G.
NEUROLOGY 2006;66:S97-S101
© 2006 American Academy of Neurology

Brain and brawn

Parallels in oxidative strength

P. I. Moreira, MA, K. Honda, MD, PhD, X. Zhu, PhD, A. Nunomura, MD, PhD, G. Casadesus, PhD, M. A. Smith, PhD and G. Perry, PhD

From the Institute of Pathology (P.I.M., K.H., X.Z., G.C., M.A.S., G.P.), Case Western Reserve University, Cleveland, OH; the Center for Neuroscience and Cell Biology of Coimbra (P.I.M.), University of Coimbra, Coimbra, Portugal; and the Department of Psychiatry and Neurology (A.N.), Asahikawa Medical College, Asahikawa, Japan.

Address correspondence and reprint requests to Dr. George Perry, Institute of Pathology, Case Western Reserve University, 2085 Adelbert Road, Cleveland, OH 44106; e-mail: george.perry{at}case.edu

Neuronal oxidative stress occurs early in the progression of Alzheimer disease (AD), significantly before the development of the pathologic hallmarks, neurofibrillary tangles, and senile plaques. Study of Down syndrome, cases with autosomal dominant mutation, and sporadic AD all suggest amyloid-β deposition and hyperphosphorylated {tau} function as compensatory responses and downstream adaptations to ensure that neuronal cells do not succumb to oxidative damage. Amyloid-β and {tau} hyperphosphorylation also define vulnerable muscle cells in sporadic inclusion-body myositis (s-IBM). The role of the structural changes of s-IBM, as in AD, remains to be determined but may mark a critical response yielding a novel balance in oxidant homeostasis.


This article was previously published in electronic format as an Expedited E-Pub at www.neurology.org.

Supported by the National Institues of Health, the Alzheimer's Association, Philip Morris USA Inc., and Philip Morris International.

Disclosure: The authors report no conflicts of interest.

Received June 22, 2005. Accepted in final form October 14, 2005.




This article has been cited by other articles:


Home page
BMJHome page
S. A Greenberg
How citation distortions create unfounded authority: analysis of a citation network
BMJ, July 23, 2009; 339(jul20_3): b2680 - b2680.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. E. Finch
A perspective on sporadic inclusion-body myositis: The role of aging and inflammatory processes
Neurology, January 24, 2006; 66(1_suppl_1): S1 - S6.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.